Parkinson's disease. Previous research has been conducted on falls-prevalent or advanced disease cohorts.
INTRODUCTION
The debilitating effect of falls for people with Parkinson's disease (PD) is axiomatic. While rates of occurrence vary, on average 61% of people with PD fall each year compared with 33% older adults. 1 Interventions to reduce falls range from inter-disciplinary falls prevention programmes to administration of single therapies. Evidence reports a beneficial effect of exercise in reducing falls rate 2 , especially in mild disease 3 and interest in pharmacological treatments such as cholinesterase inhibitors 4 including rivastigmine 5 is growing. Despite targeted interventions, falls are a persistent clinical feature. Part of the reason for this is that studies that test therapeutic efficacy have to date been restricted to falls-prevalent cohorts (single or recurrent falls) rather than falls-naïve cohorts.
Interventions are obliged therefore to target secondary risk factors that occur in response to experiencing falls (eg fear of falling, deconditioning due to reduced mobility) as well as primary risk factors. Over time primary and secondary risk factors conflate, further confounding the issue.
Understanding falls risk and the emergence of falls behaviour in fall cohorts is critical to inform effective treatment strategies and current predictive models do not fully instruct. Despite focused research over two decades, the strongest predictor of a future fall is a previous fall 6 which has obvious limited clinical and research utility. Studies that have examined risk factors for first fall are carried out in PD cohorts with average disease duration of five or six years 7, 8 which does not inform about early intervention. It is timely to examine risk factors in early disease to identify characteristics that signal transition from non-faller to faller and inversely highlight protective features. Falls aetiology in PD is complex due to the progressive, heterogeneous nature of the disorder, and its interaction with agerelated pathophysiology and associated comorbidities necessitates a comprehensive measurement battery. A European task force recently recommended assessment of 31 falls-risk characteristics (16 disease-related and 15 age-related), 9 highlighting the challenges associated with clinical prediction.
The aim of this study was to identify predictors of first fall over 36 months in an early, falls-naïve PD cohort. Because we were interested in predictors of first fall we did not assess falls recurrence. Based on previous work we hypothesised that age, gait variability, attention and disease severity would emerge as significant predictors and falls would be greater in the postural-instability and gait disturbance (PIGD) phenotype.
METHODS

Participants
Participants were recruited into ICICLE-GAIT within 4 months of diagnosis. This is a collaborative study with ICICLE-PD, an incident cohort study 16 Balance self-efficacy was measured using the Activities Balance Self Confidence Scale 17 and depression with the Geriatric Depression Scale (GDS). 18 Freezing of gait (FoG) was measured using the NFOG questionnaire and presence or absence of FoG was calculated from the NFOG score 19 Levodopa equivalent daily dose (LEDD) scores were calculated for each patient.
Systolic and diastolic blood pressures were recorded in the supine position after ten minutes rest and then 3 minutes after standing. Orthostatic hypotension (OH) was defined as a 20mmHg fall in systolic BP and /or a 10mmHg in diastolic BP. 21 Co-morbidities were described by self-report and non-PD medications were collated from prescription scripts and clinic notes.
Gait assessment and outcomes
Gait was assessed using a 7m long x 0.6m wide instrumented walkway (Platinum model Gaitrite, software version 4.5, CIR systems, United States of America). Participants were instructed to walk at their comfortable walking pace for two minutes around a 25m oval circuit under single and dual task conditions. 14, 22 We measured 16 independent gait characteristics that conform to a model of gait that has been validated in PD and comprises 5 independent domains. 
Falls diaries
A fall was defined as 'unintentionally coming to rest on the ground or other lower surface without being exposed to overwhelming external force or a major internal event' 28 and falls were recorded prospectively using Prevention of Falls Network Europe (PROFANE) recommendations. 28 Falls diaries were sent out on a monthly basis with a pre-paid return envelope in which participants were asked to record if they had fallen in the past month. If so, they were prompted to provide the date and time of each fall as well as location, preceding activity, perceived cause, position in which they landed on the floor and mode of recovery. All falls reported in the diaries were followed-up with a telephone call from a senior research physiotherapist (DM, HH) to verify information and rectify any missing data.
Data analysis
We used a data-driven approach to conduct a staged analysis. Falls status at 36 months was described and between-group (single faller v non-faller) differences examined using Students-t-test and Chisquare test. Gait data were transformed as described previously 14 . We used Chi Square Automatic
Interaction Detection (CHAID) tree analysis to identify significant predictors for inclusion in prediction models. 29 sensitivity and specificity metrics derived from a 2x2 contingency table. We entered a comprehensive range of demographic, clinical, behavioural, cognitive and gait predictors into CHAID (see Table 1 ).
Single task gait variables were entered initially with all predictors, and the model then replicated with dual task gait variables. Survival analysis was conducted with Cox regression and time to first fall was plotted using Kaplan-Meier curves for the larger cohort (n = 91) which included n = 14 with left censored data (incomplete diaries). Dichotomous predictors identified by CHAID were entered into Cox regression analysis using the enter model (independent predictors were entered simultaneously) and time to first fall over 36 months as the dependent variable. Finally, we used Cox regression to estimate hazard ration (HR) of falls risk from cumulative risk factors. Data from participants who did not complete all of the falls diaries was retained in the survival analysis as censored data. Figure 1 describes the flow of participants. One hundred and twenty one people with incident PD were recruited into ICICLE-GAIT. At baseline, 26 (22%) participants reported at least one fall in the past year. Two participants were re-diagnosed and two did not participate in the falls study, leaving a total of 91 participants. A total of 14 falls diaries were incomplete leaving 36 months falls data for 77 participants who comprised the falls-naïve, falls-risk cohort. Of these 77 participants, 47 (61%)
RESULTS
reported at least one fall; 18 (38%) reported single falls and 29 (62%) reported recurrent falls.
Characteristics of fallers and non-fallers and between-group differences are reported in Table 1 . When compared with non-fallers, fallers presented with significantly higher disease severity as measured by the PIGD score, a slower gait speed, increased stance time variability and higher swing time asymmetry. A total of 15 participants (19%) scored III on the H&Y scale, with 13 identified as fallers.
The proportion of participants classified as PIGD was higher for fallers (n = 26; 55%) than non-fallers (n = 11; 23%) although this was not significant. Two fallers and two non-fallers reported FoG. Single leg stance was significantly worse for fallers. There were no significant differences for cognitive outcomes, although there was a trend towards significance for MoCA visuospatial task and subjective cognitive complaint. Other outcomes bordering on significance included H&Y score, motor phenotype, balance self-efficacy (ABC score), step length, step and swing time variability. The use of levodopa medication did not distinguish fallers from non-fallers. Co-morbidities for both groups were low and were not significantly different (see Table 1 ).
CHAID analysis identified thresholds for three significant predictors for falls at 36 months (Fig 2) .
Participants were initially dichotomised by gait speed (1.13m/s), with slow gait speed classifying 30/38 (79%) as fallers. The remaining 39 participants with gait speed >1.13m/s (which included 17 (44%) fallers) were split by H&Y. Four participants were categorised as H&Y III, and all were fallers.
The remaining 35 participants were H&Y I or II, and of these 13 (37%) were fallers. This group was then subjected to a third, final split. A mean stance time ≤ 659ms identified 9/13 (69%) of fallers and stance time > 659ms classified 4/22 (18.2%) as fallers. Overall, sensitivity and specificity of the model was 43/47 (92%) and 18/30 (60%) respectively, with an accuracy of 79%. CHAID failed to identify any further independent predictors when the model was run using dual rather than single task gait variables.
Survival analysis showed that median time to first fall was 847 days (95% CI 628 to 1065 days) ( Fig   3A) . Gait speed, H&Y and stance time were retained as independent predictors in the Cox model.
The HR was over three times higher for a participant presenting with slow gait speed (HR 3.44) with similar risk associated with stance time ≤659ms, with a HR of 3.31.H&Y III yielded a HR of 2.80 (Table 2 , Fig 3B) . The cumulative effect of slow gait speed, fast stance time and H&Y III resulted in a HR of 7.82 ( Table 2) . Inspection of residual plots and statistical testing indicated that the assumption of proportionality was not violated (P = .720).
DISCUSSION
Use of a falls-naïve cohort in this study yielded entirely novel data that for the first time directs the clinician toward strategies for primary prevention or delay to first fall. This is the first report to our knowledge of prospective falls in a newly diagnosed, falls-naïve cohort employing robust methodology for falls ascertainment and an extensive test battery. Risk of falling was almost eight times higher for someone presenting with slow gait speed, decreased stance time and H&Y III. Our hypothesis was partly supported in that motor features dominate the model although disease severity, age and attention did not emerge as significant predictors. Importantly, incidence of falls was high for this cohort. Survival analysis indicates that the first fall occurs soon after diagnosis, highlighting the need for early intervention. Our model yielded high sensitivity (91%) although specificity was only moderate (60%). Given the trajectory of gait dysfunction and falls in PD, however, we argue that it is more important to be sensitive than specific.
The strongest predictor was gait speed followed by stance time and H&Y stage. The estimate for gait speed identified by CHAID was 1.13m/s, as found in earlier work in falls prevalent cohorts. Paul and colleagues 30 identified a threshold of 1.1m/s for gait speed as a significant falls predictor which was then replicated in a follow-up study 31 . This suggests that gait speed reaches a threshold early on but does not attenuate as disease advances. Gait speed as a predictor of falls in our early cohort is not surprising. Reduced gait speed is a cardinal feature of parkinsonian gait, driven by hypokinetic step length due to dysregulation of motor set from disturbed activity in basal ganglia-supplementary motor area pathways. 32, 33 Stance time was also retained as a predictor in our model and was shown to be stronger than H&Y score. Risk for falls was greater for those participants with a comparatively shorter stance time if they presented with better motor control (ie they were H&Y I or II and walked faster). A shorter stance time indicates early temporal dysregulation of gait, although may also be interpreted as a compensatory response for regulating step length. 33 A strength of our predictive model is that it comprised temporal and spatial gait features which are at least to some extent independent. In PD this is exemplified by their selective response to levodopa, with temporal but not spatial characteristics refractory to medication. 34 H&Y stage was selected as a predictor by CHAID for participants with faster gait speed (>1.13m/s), and was retained in the Cox model over and above motor phenotype or disease severity although PIGD score was significantly different at 36 months for fallers and non-fallers. The defining feature of H&Y III (the threshold identified by CHAID) is the presence of impaired postural reflexes, charaterised by the 'pull back' test which tests reactive postural responses via the ability to recover from sudden retropulsion. Postural control is impaired in PD even in the early stages, 35 and the influence of balance dysfunction on falls is well established. 36 The coupling of gait and postural control reflects motor system integrity and both are required for safe and effective locomotion.
Clinical screening for falls risk is common, and two of the three risk factors we identified (gait speed and H&Y stage) can be measured in the clinic without the need for specialist equipment. Whilst it is tempting to rely on the H&Y scale because of its relative simplicity, it is important to note its limitations. H&Y III was highly sensitive (100%) to fallers who present with fast gait speed, but H&Y Comparison of our model with previous research is limited because of methodological differences.
Most earlier work has been carried out on falls-prevalent cohorts where a positive fall history dominates models of risk. Exceptions to this include two studies where a falls-naïve cohort has been examined in moderately advanced disease. The first examined predictors of first fall in a PD cohort of over 5 years duration 7 , with self reported disability emerging as the only sigificant predictor in the model which the authors report as low accuracy (AUC 0.65). Similarly, Kerr and colleagues applied a multivariate model (comprising UPDRS score, OH, postural sway and Tinetti score) derived from a falls-prevalent cohort with average disease duration of 6 years to a subgroup of participants from the same study who were falls-naïve. The authors reported 77% sensitivy and 72% specificity for falls 8 .
Whilst both studies inform about risk factors for first fall, it is important to note that in more advanced cohorts these are likely to be different because PD pathology becomes more complex over time.
Future analysis from the ICICLE-GAIT database will allow us to examine the evolution of falls prediction as disease advances. Also, the high transition rate to falls in this early cohort indicates the challenges of establishing a truly falls-naïve cohort later in the disease.
A nuanced assessment of gait and cognition in our study allowed for more detailed interpretation of their association with falls. We were surprised to find that gait variabilty which is associated with falls frequency 39 was not a risk factor; possibly because gait variability was less pronounced in this early cohort. Use of dual task gait variables did not inform analysis, possibly because response to walking under dual task conditions is highly variable. 40 Inclusion of a comprehensive battery of gait and cognitive characteristics in this study allowed us to examine more fully the contribution of both to falls risk. We also expected cognition to play a stronger role given its assocation with falls and gait even in early PD, and the contribution of attention to falls in PD. 41 Cognitive outcomes for both groups were highly comparable and of interest is that visuospatial function, measured by item 1 of the MoCA, trended towards significance. Age did not emerge as a significant predictor possibly because of the relatively young age of the cohort, and similarly medication use did not discern fallers from non-fallers, possibly because the (identical) mean dosage for both groups was fairly low at 164 mg.day -1
. Co-morbidities and use of non-PD medication were overal low, reflecting the age and good general health of the cohort. FoG did not emerge as a significant predictor as in previous work, again reflecting the early nature of disease.
Understanding predictors of falls for this falls-naïve cohort provides a basis for evidence-based interventions in early disease cohorts. Interventions are likely to be both pharmacological and exercise-based, with both co-inciding to optimise outcome. The recent paper by Henderson provides preliminary evidence for efficacy of Rivastigmine as an acetylcholinisterase inhibitor to improve gait variability (a proxy for falls) in a falls-prevalent PD cohort 5 . Use of on-line cueing strategies is also effective early on, although for some people on-line cueing will be required on a continual basis to optimise response. 42 Timing of interventions is important. Pre-planned post-hoc analyses from a recent RCT examining the effects of an exercise intervention on rate of falls in a falls-established cohort reported a positive effect for participants with lower disease severity whilst there was a trend toward more falls for those with higher disease severity 3 stressing early intervention as a priority.
However, aetiology of falls in PD is complex with synergistic risk factors; some of which may be more amenable to intervention than others.
We used CHAID to identify predictors because the decision-tree analysis aids interpretation and has strong clinical utility. A recent comparion of linear and non-linear data analysis techniques for falls prediction showed highly comparable metrics for logistic regression and CHAID analysis, suggesting it is a valid approach 38 . Replication of the model on a larger sample using a similar methodology is essential to confirm findings. The sample size limited our ability to validate the CHAID decision tree by applying the model to a test data set and our training set may have produced some chance categorisation.
Our primary concern was to identify targets for intervention prior to the first fall, well in advance of falls becoming a routine feature. Recurrent fallers are therefore not relevant to our analysis although we appreciate the sample size would increase if we categorised fallers as such. We anticipate that recurrent fallers will show a broader array of predictors compared to the three we identified because of confounding effects, however this is speculative and can only be tested in future analysis. The In summary, this study provides novel and robust evidence for prediction of falls over 36 months in a falls-naive cohort of early PD. Our results provide direction for interventions in the very early stages of the disease which must be targetted towards improving gait dysfunction and postural strategies where these risk factors are identified. Future research will evaluate the impact of addressing these risk factors early on and potentially delay onset to first fall. 
